Impact of Health Care Insurance Status on Treatment Outcomes of Acute Myeloid Leukemia
Insurance status has been found to influence treatment outcomes in various solid tumors, but limited data is available for patients with acute myeloid leukemia (AML). A total of 161 patients were included in this retrospective study to examine the impact of insurance source in AML outcomes in the state of Oklahoma. Insurance source at diagnosis was found to have no impact on AML treatment outcomes and receipt of bone marrow transplant. The consistency of our results with some, but not all, studies is probably driven primarily by access-to-care requirements among different states.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Samer A. Srour, Michael Machiorlatti, Namali T. Pierson, Usman Z. Bhutta, Mohamad Cherry, George B. Selby, David M. Thompson, Sara K. Vesely, Carla D. Kurkjian Tags: Original Study Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Bone Marrow Transplant | Health Management | Hematology | Insurance | Leukemia | Lymphoma | Myeloma | Study | Transplants